Advertisement
News
Subscribe to MDT Magazine News

Malignant brain tumors: Benefit of PET and PET/CT in the detection of recurrences is not assessable

January 19, 2011 9:45 am | by EurekAlert | Comments

(Institute for Quality and Efficiency in Health Care) Malignant gliomas are fast-growing brain tumors with poor prospects of recovery depending on disease stage. Experts hope that the examination of patients by means of positron emission tomography (PET) is more helpful in the...

TOPICS:

HIV-positive head and neck cancer patients benefit from radiation therapy

January 19, 2011 9:45 am | by EurekAlert | Comments

(American Society for Radiation Oncology) HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience similar toxicity rates as non-HIV-positive patients, despite prior reports to the contrary, according to a study in the January issue of...

TOPICS:

Boston's game, health care and IT expertise drive social games for health

January 19, 2011 8:44 am | by Mass High Tech: The Journal of New England Technology | Comments

Games are hot, and so is health IT. Boston combines a growing video game sector, a storied IT sector, and a global leadership position in health care. It should come as no surprise that the city is proving a seed bed for startups at the intersection of the two trends.

Advertisement

CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions

January 19, 2011 8:37 am | by Bio-Medicine.Org | Comments

WOONSOCKET, R.I., Jan. 19, 2011 /- When consumers are offered a cost-neutral choice to fill their 90-day prescription medications in a retail store or through a mail-order pharmacy, they split their preferences largely depending on their past experiences, a first-of-its-kind study from...

TOPICS:

NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump® and ResQPOD® CPR D...

January 19, 2011 8:35 am | by Bio-Medicine.Org | Comments

ROSEVILLE, Minn., Jan. 19, 2011 /- A combination of two devices could save the lives of thousands of cardiac arrest patients each year if implemented nationwide, suggests clinical trial results published in today's online edition of The Lancet. A significantly higher percentage of...

TOPICS:

New European collaboration on cancer research

January 19, 2011 8:34 am | by EurekAlert | Comments

(Karolinska Institutet) Europe's leading oncology organizations are combining forces in the global fight against cancer. The project, EurocanPlatform, has received ?12 million ($16 million) from the European Union to streamline cross border research. The project will find more effective...

TOPICS:

Featured Search — Perfusion CT Predicts Feared Consequences of tPA-Treated Stroke

January 19, 2011 8:34 am | by Diagnostic Imaging | Comments

A small study reveals that perfusion CT findings of blood-brain barrier permeability above a specified volume at the time of admission in patients over the age of 65 treated with tPA can predict two “feared complications”-symptomatic hemorrhagic transformation and malignant edema-with 100...

TOPICS:

QBC Diagnostics Announces the Availability of the ParaLens Advance LED Fluorescence Microscopy Attachment

January 19, 2011 8:33 am | by Bio-Medicine.Org | Comments

PORT MATILDA, Pa., Jan. 19, 2011 /- QBC Diagnostics is pleased to announce the release of the QBC ParaLens Advance, a breakthrough product that can easily upgrade any compound light microscope for LED fluorescence microscopy. The ParaLens Advance builds on the proven success of the...

TOPICS:
Advertisement

CDRH Plan of Action for 510(k) and Science

January 19, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

Information on steps CDRH is taking to foster medical device innovation and assure the safety and effectiveness of medical technologies used in the United States.

TOPICS:

CDRH 2011 Strategic Priorities

January 19, 2011 8:30 am | by U.S. Food & Drug Administration | Comments

As we release our 2011 Strategic Priorities, we are proud to report on our accomplishments from 2010. In addition to meeting our 85 percent achievement goal by September 30, 2010, we also had met 91 percent of actions with due dates by December 31, 2010..

TOPICS:

Targacept schizophrenia drug meets study goal

January 19, 2011 7:45 am | by The Associated Press | Comments

Targacept Inc. said Wednesday its potential schizophrenia drug met a key goal of improving cognition in patients in a midstage study.The study involved patients with stable psychotic symptoms who were taking other anti-psychotic medications. The 185-person study then compared results from...

Vermont AG settles data breach case for $55,000

January 19, 2011 6:45 am | by The Associated Press | Comments

The Vermont Attorney General's office says a Connecticut-based health insurance company is ready to pay $55,000 to settle a complaint that it didn't inform customers that personal information had been lost along with an unencrypted computer hard drive.The state says the complaint and proposed...

Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom

January 19, 2011 4:44 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, Jan. 19, 2011 /- Wolters Kluwer Health today announced a joint venture with leading China drug information provider Medicom to deliver clinical decision support to doctors in China as the country prepares for significant changes to its healthcare system. The deal allows...

TOPICS:

SMA Foundation and Rules-Based Medicine Collaborate on Biomarker Panels to Guide SMA Therapeutic Development

January 19, 2011 4:44 am | by Bio-Medicine.Org | Comments

NEW YORK and AUSTIN, Texas, Jan. 19, 2011 /- The Spinal Muscular Atrophy (SMA) Foundation and Rules-Based Medicine, Inc. (RBM) announced today that they have reached the first milestone in a program to develop a panel of plasma protein biomarkers for SMA using RBM's Multi-Analyte...

TOPICS:

Nuance Health Introduces Swype, an Innovative New Product Designed to Enhance Defense Against Colds and Flu

January 19, 2011 4:38 am | by Bio-Medicine.Org | Comments

PONTE VEDRA BEACH, Fla., Jan. 19, 2011 /- Nuance Health, LLC, a company that develops products designed to help people maintain good health, today introduced Swype, a new product that enhances defense against viruses at the body's most vulnerable spot – the nose.  In...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading